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Summary: An assay of adenosine deaminase activity in pleural effusions is described. For the continuous
determination of adenosine deaminase, the liberated ammonia is estimated by coupling the liberated NH3
with 2-oxoglutarate. The reaction is followed by the decrease of NADH absorbance at 340 nm. The assay
was optimized for a Hitachi 705 analyser, with respect to pH, adenosine concentration and glutamate
dehydrogenase activity. The assay is linear to an adenosine deaminase catalytic concentration of 110 U/l.
Elevated adenosine deaminase activities are föund in pleural effusions of patients with tuberculosis, empyema
and mesothelioma. Although elevated adenosine deaminase activity in pleural effusion is not pathognomonic
for tuberculpsis, it may be valuable äs a first screening parameter.
Eine Methode zur kontinuierlichen Messung von Adenosindesaminase in Pleuraexsudaten mit dem diskreten
Analysator Hitachi 705
Zusammenfassung: Eine Bestimmungsmethode für Adenosindesaminase in Pleuraexsudaten wird beschrieben.
Zur kontinuierlichen Bestimmung von Adenosindesaminase wird das freigesetzte Ammoniak mit 2-Oxogluta-
rat umgesetzt. Die Reaktion wird durch Messung des NADH-Verbrauchs bei 340 nm kontinuierlich verfolgt.
Die Methode wurde hinsichtlich pH, Adenosinkonzentration und katalytischer Konzentration von Glutamat-
dehydrogenase für den Hitachi 705 optimiert. Die Methode ist linear bis 110 U/l Adenosindesaminase. Erhöhte
katalytische Konzentrationen werden in Pleuraexsudaten bei Tuberkulose, Empyem und Mesotheliom gefun-
den. Obwohl die erhöhte Adenosindesaminase nicht pathognomonisch für Tuberkulose ist, kann sie als ein
erstes Merkmal für das Screening wertvoll sein.
Introduction
 for the differentiation of lymphoid cells, particular T
Adenosine deaminase (EC 3.5.4.4) is a widely dis- cells (1) and maturation of monocytes to macro-
iributed enzyme, which catalyses the hydrolysis of phages (2). Its deficiency in the lymphocytes results
adenosine to inosine and ammonia in the purine in severe combined immunodeficiency disease (3, 4).
catabolic pathway. Adenosine deaminase is essential Elevated adenosine deaminase activity is found in
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serum of patients with infectious mononucleosis (5),
acute leukaemia (8), typhoid fever (6), liver diseases
(7, 10) and sarcoidosis (18). In pleural effusions of
patients with tuberculosis, empyema and rheumatoid
pleural effusion, higher adenosine deaminase ac-
tivities are reported than in malignant or para-
pneumonic pleural effusions (9 — 13). The adenosine
deaminase activity may be measured by de-
termination of the rate of either consumption of
adenosine or of formation of inosine or ammonia.
The determination of produced ammoiiia is mostly
used in routine measurements. The ammonia can be
determined by the indophenol reaction (Berthelot)
(14, 15) or by coupling the liberated NHa to 2-oxo-
glutaric acid with glutamate dehydrogenase (EC
1.4.1.3). The last method has the advantage that
the overall reaction can be followed by the rate of
consumption of NADH.
We have adapted this method for measurement with
a Hitachi 705 discrete analyser, in order to st dy the
usefulness of adenosine deaminase determination in
the evaluation of the origin of pleural effusions.
Tab. 1. Final concentfations of reagents.
Materials and Methods
Reagents
1. Phosphate buffer 0.25 mol/1 pH 7.5:
39.0 g Na2HP04 · 2H2O, 4.2 g KH2PO4 in l litre distilled
water.
2. Adenosine (Boehringer Mannheim, FRG) 300 mmol/1):
suspend 2.0 g in 20 ml distilled water and add dropwise 360
g/kg HC1 until the adenosine is dissolved. Adjust to 25 ml
with distilled water. Stable for l month at —20 °C.
3. Glutamate dehydrogenase in glycerol, 1200 kU/1 (Boehringer
Mannheim, FRG, 127710).
4. 2-Oxoglutaric acid (Boehringer Mannheim, FRG) 0.2 mol/1:
dissolve 2.9 g in 100 ml distilled water and neutralize. Stable
for l month at -20°C.
5. NADH, disodium salt (Boehringer M nnheim, FRG, Grade
I), ± 21 mmol/1:
dissolve 15 mg/ml distilled water. Prepare fresh daily.
6. ADP, disodium salt (Boehringer Mannheim, FRG) 90
mmol/1:
dissolve 425 mg ADP in 10 ml distilled water.
In the final reagent 15 ml phosphate buffer is mixed with 300
μΐ glutamate dehydrogenase Suspension, 200 μΐ 2-oxoglutaric
acid solution, 250 μΐ NADH solution, 300 μΐ ADP solution
and 1250 μΐ adenosine solution. The pH is adjusted to 7.25 +
0.05. The final concentrations of the reagents are given in
t ble 1.
The unspecific activity is measured under the same conditions
with buffer instead of adenosine in the final reagent.
pH
Phosphate buffer
Adenosine
Glutamate dehydrogenase
2-Oxoglutaric acid
NADH
ADP
7.20-7.30
0.22 mol/1
21.7 mmol/l
21 kU/1
2.3 mmol/1
0.33 mmol/1
1.56 mmol/1
Samples
The pleural effusions were centrifugated at 1000g 15 min and
stored at —20 °C until assayed. The adenosine deaminase ac-
tivity was unaltered for at least 4 months at —20 °C.
No difference was found between serum, heparin plasma and
EDTA plasma. Haemolytic samples with a concentration up
to 0.24 mmol/1 haemoglobin have no effect on the adenosine
deaminase activity (tab. 2).
Tab. 2. Influence of haemolysis on the adenosine deaminase
activity in serum at 37 °C
Adenosine deaminase
(U/0
Serum 23.5
H- 0.08 mmol/1 haemoglobin 22.9
H- 0.12 mmol/1 haemoglobin 23.9
+ 0.24 mmol/1 haemoglobin 23.3
Procedure
 f .
The Hitachi 705 discrete analyser (Boehringer Mannheim,
FRG) was operated according to the usual protocpl, the settings
being shown in table 3. The optimazation of the cpntinuous
method was performed on an Acta II spectrophotometer (Beck-
man Instr., NY, USA).
The molar lineic absorbance, ε = 622 m2/mol at 340 nm, was
used for NADH. With a reference wavelength of 660 nm on
the Hitachi 705 discrete analyser, the molar iineic absprbatice,
ε 340/660 of 589 m2/moi was used.
The activity in U/l is defmed s the quantity of NH3 produced
in μπιοί per minute per litre.
Tab. 3. Parameter listing for detefmination of adenosine
deaminase activity at 37 °C on a Hitachi 705 discrete
analyser.
Assay code
Sample volume
Wavelength l
Wavelength 2
Factor
Abs. limit rate
2 (rate)-20-28
20 μ!
350 μΐ
Ο
660 nm
340 nm
3161
2000 (0.2 A)
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Rcsults
p H - o p t i m u m
To determine the optimal pH for the assay, phosphate
buffers ranging in pH (Vorn 6.9 to 7.5 are used. An
optimal pH for the enzyme activity in the final re-
agent was found between 7Λ and 7.3 (fig. 1). In the
final procedure a final pH of 7.25 ± 0.05 was chosen.
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Fig. 1. Influence of pH on the adenosine deaminase activity in
pleural effusion (o) and serum (o).
Optimal concentration of reagents
The reaction time in the assay is limited by the use
of the Hitachi 705 analyser, the measurement has to
be completed within 10 minutes. As the endogenous
ammonia and other Substrates causing non-specific
NADH consumption are eliminated within ± 6 min-
utes, there is a period in which the decrease of the
absorbance each 20 seconds can be measured and the
linearity of the assay can be controlled. In figure 2
the rate of ammonia consumption is plotted s a
function of the glutamate dehydrogenase activity. A
glutamate dehydrogenase activity of 20 kU/1 in the
presence of 1.5 mmol/1 ADP and 4 mmol/1 2-oxo-
giutarate is sufficient to eliminate 700 μιηοΐ/ΐ am-
monia within 6 minutes. ADP in a concentration of
1.5 mmol/1 is added to activate the glutamate de-
hydrogenase, according to the literature (16).
The adenosine concentration is varied between 5 and
27 mmol/1. The influence of the adenosine con-
centration on the adenosine deaminase activity is
given in figure 3. From a Lineweaver-Burk plot a
0.400 -
0.300
o 0.200 -
0.100 -
t Lmin J
Fig. 2. Consumption rate of NH3 (700 μπιοΐ/ΐ) s function of
the glutamate dehydrogenase activity at 37 °C: 11 U/l
(o), 22 U/l (D), 44 U/l (A).
0.030
0.020
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10 20
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Fig. 3. Influence of the adenosine concentration on the adeno-
sine deaminase activity in pleural effusion (o) and serum
(n).
mmol/1 in pleural effusion from tuberculosis and Km =
3.4 mmol/1 in a serum, thereby demonstrating the
presence of various isoenzymes (4, 14). At a final
adenosine concentration of 21.4 mmol/1, the adenosine
deaminase activities are 86% and 89% of Kmax for
the pleural effusion and serum, respectively. Higher
adenosine concentration in the final reagent are not
used because the adenosine tends to crystallize out.
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Precision
The intra-run precision in the lower r nge is 2.4%
(x = 26.0, n = 25) and in the elevated r nge 2.1%
(x = 88.4, n = 25).
Unspecific activity
The unspecific activity in pleural effusions was meas-
ured in 119 patient samples. The mean activity was
4.6 U/l and the r nge (x ± 1.96 σ) is 0.2 - 9.5 U/l.
A maximal unspecific activity of 12.3 U/l was found.
Adenosine deaminase in pleural effusions
The adenosine deaminase activities among the
various groups of lung diseases are compared in
figure 5. The patients are subdivided into 5 groups:
I tuberculosis (4 x),
II empyema (7 x),
III mesothelioma (lOx),
IV other malignant neoplasms (32 x),
V patients with pneumothorax (9x), para-
pneumonic effusions (14x), haematothorax
(2 x), congestive heart failure (2 x), and unspe-
cific pleural effusions (10 x).
One patient in group V, with a Budd-Chiari syndrome
with ascites, had an unspecific pleural effusion in
which the adenosine deaminase activity was 81 U/l.
However, the adenosine deaminase activity in serum
(117 U/l) was also elevated. No significant difference
is found between group IV and V (Student t-test).
From these two groups a distribution-free 98th
percentile of 44 U/l is found.
150
Linear i ty
The upper limit of enzyme activity at which a linear
response can be obtained is determined by using
mixtures of pleural effusions with a low adenosine
deaminase level (sample A: 11 U/l) and a high adeno-
sine deaminase level (sample B: 1.84 U/l). The fraction
of pleural effusion B in the mixture of pleural effusion
A and pleural effusion B is given in figure 4. The
calculated regression line is: ^
ADA (obs) U/l = 173 · fraction of sample B + 11.1. | 100
Using an upper limit of 110 U/l a correlation co-
efficient r = 0.9990 is obtained.
o
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Fig. 4. Linearity of the adenosine deaminase assay. Pleural
effusion B (184 U/l) is mixed with pleural effusion A (11
U/l).
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Fig. 5. Adenosine deaminase activity in pleural effusion in
various disOrders.
The line (— ) shows the 98th percentile of group
IV and V.
Discussion
Pleural effusions are frequently a diagnostic problem
in clinieal practice. A careful diagnostic evaluation
of the aetiology of the effusion cannot be est blished
in about 20% of patients (11). The estimation of
adenosine deaminase in pleural effusions appeared to
be a valuable aid in the diagnosis of tuberculous
pleural effusions. Although the incidence of tu-
berculosis has decreased, this disease still has to be
taken into account in the differential diagnosis of
pleural effusions.
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Our intention was to look for a fast and simple test
to make or exclude the diagnosis of tuberculosis, in
order to avoid the necessity to prepare cultures for
the identification of Mycobacterium tuberculosis, or
to prepare biopsies of parietal pleura to look for
epithelioid granulomas. The method for de-
termination of adenosine deaminase activity by me-
ans of the Berthelot reaction (11, 15) is rather time-
consuming, therefore we adapted and optimized the
enzymatic method for the estimation of the adenosine
deaminase activity on a Hitachi 705 discrete analyser.
The resulting enzymatic method gave a high quality
performance.
Ratech & Hirschhorn (4) have investigated the kinetic
properties and molecular mass of the adenosine de-
aminase (ADA) isoenzymes. They reported a mon-
omeric 35000 dalton isoenzyme ADAj, an 280000
dalton isoenzyme, containing 35 000 dalton catalytic
units with a nonenzymatic 200000 dalton combining
glycoprotein ADAi,Gp and a 100000 dalton iso-
enzyme ADA2. The reported Km values for AD AI
and ADA1$GP are 51 μπιοΐ/ΐ and 75 μιηοΐ/ΐ, respectively.
For ADA2, Km = 2800 μπιοΐ/ΐ. Also the Kmax values
for AD A! and ΑΟΑί%Ορ are more than 10 times less
than that for ADA2.
Notably, a child with severe combined immuno-
deficiency (SCID), showed a complete absence of
ADA] and ADA^op in lymphocytes, erythrocytes
and other tissues. The serum ADA2 activity was nor-
mal. These different kinetic properties of the adeno-
sine deaminase isoenzymes are a confirmation of the
work of Ellis & Goldberg (16).
In tuberculous pleural effusion, we found a Km of 4.8
mmol/1 for the adenosine deaminase enzyme. We were
therefore pr bably dealing with the ADA2 type iso-
enzyme. For this reason, it becomes clear that the
correlation with the number of lymphocytes in the
pleural effusion, s sought by Pettersori (17) and
Ocana (l 2 a) will not be found; the lymphocytes con-
tain only ADAj type isoenzyme and in our and their
assay the adenosine concentration is too high. At the
adenosine concentration used, the conversion rate V
is about 88% of Fmax for adenosine. With the large
difference in Kmax for the ADA] type and ADA2 type
isoenzyme (4), the ADA, is obscured in a medium
where ADA2 type enzyme is present in at least the
same order of magnitude. Accordingly, and in con-
tradiction with the literature (10, 15), our assay is
not influenced by haemolysis. However, further study
is necessary to clarify the origin and characterization
of adenosine deaminase in tuberculous pleural ef-
fusions. Possibly the adenosine deaminase in tu-
berculous pleural effusions originates from the epi-
thelioid granulomas.
Our clinical results are shown in figure 5. The di-
agnosis of tuberculosis was confirmed by culture.
There was no evidence of culture negative tu-
berculous pleural effusions in our population. From
this small data group it appears that tuberculous
pleural effusions have a significantly higher adenosine
deaminase activity than pleural effusions of group IV
and V (Student t-test, p < 0.005). With the exception
of the results of Blake et al. (11), our results are in
concordance with the literature (tab. 4). There is a
discrepancy between the results of Blake et al. (11)
and the other reported data (tab. 4). An explanation
cannot be given, because Blake et al. give no speci-
fication of the used pH, buffer concentration and
glutamate dehydrogenase activity.
As can be seen from figure 5, the adenosine de-
aminase activity in pleural effusions does not dis-
criminate between tuberculosis, empyema and me-
sothelioma, when there is a normal blood level of
adenosine deaminase activity. In the literature high
values of adenosine deaminase activity are also de-
scribed in pleural effusions from patients with rheu-
matoid arthritis (17). Consequently, elevated adeno-
sine deaminase activity in pleural effusions is not
pathognomonic for tuberculosis.
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Tab. 4. Reported adenosine deaminase activity in tuberculous pleural effusions at 37 °C
Authors
Piras et al.
Blake & Berman
Ocana et al.
Pelterson et al.
Present
Ref.
(9)
(11)
(12b)
(13)
n
21
82
103
14
4
χ ± σ
(U/l)
83 ± 26
46 ± 13
91 ± 29
102 ± 9
80 ± 10
Obs. lower
limit
(U/l)
38
5
45
52
70
Ref.
value
(U/l)
<30
<30
<45
<50
<44
Method
I.e. (15)
GLDH/NADH
I.e. (15)
I.e. (15)
mod. I.e. (16)
Year
1978
1982
1983
1984
1985
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